Inactive Instrument

Sector Chart CytRx Corporation Nasdaq

Equities

US2328285091

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
54.63B -
39.92B
26.86B
26.22B
18.78B -
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW